🇺🇸 Recombinant human brain natriuretic peptide in United States

Recombinant human brain natriuretic peptide (Recombinant human brain natriuretic peptide) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Recombinant human brain natriuretic peptide in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Recombinant human brain natriuretic peptide approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Recombinant human brain natriuretic peptide in United States?

Shanghai Zhongshan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.